Abstract
Aim To apply the DU90% indicator (the number of unique drugs which make up 90% of a doctor’s prescribing) to GP practices prescribing in England to examine time trends, practice-level variation, and relationships with practice characteristics
Method This is an observational cohort study of all general practices in England. It utilises publicly available prescribing data from the National Health Service (NHS) Digital platform for 2013-2017. The DU90% was calculated on an annual basis for each practice based on medication BNF codes. Descriptive statistics were generated per year on time trends and practice-level variation in the DU90%. Multi-level linear regression was used to examine the practice characteristics (relating to staff, patients, and deprivation of the practice area).
Results A total of 7,623 GP practices were included. The mean DU90% ranged from 130.1 to 133.4 across study years, and variation between practices was low (with a 1.4 fold difference between the lowest and highest 5% of practices). A range of medications were included in the DU90% of virtually all practices, including atorvastatin, levothyroxine, omeprazole, ramipril, amlodipine, simvastatin and aspirin. A higher volume of prescribing was associated with a lower DU90%, while having more patients, higher proportions of patients who are female or aged 65+, higher number of GPs working in the practice, and being in a more deprived area were associated with a higher DU90%.
Conclusion GP practices typically use 130 different medications in the bulk of their prescribing. Increasing use of personal formularies may enhance prescribing quality and reduce costs.
What is already known about this subject:
Prescribers can develop expertise in a finite number of drugs, hence use of a personal formulary is recommended and may enhance prescribing quality
The drug utilisation 90% (DU90%), a measure of the number of drugs that comprises 90% of prescribing volume, has not been applied to prescribing in England to date.
What this study adds:
On average, 130 medicines make up 90% of prescribing in GP practices in England.
Practices with a lower DU90% tended to have lower prescribing costs and less prescribing considered low-value care.
Rationalising prescribing to focus on a smaller group of medicines may enhance quality and reduce costs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Health Research Board in Ireland (HRB) through the Summer Student Scholarships (grant no. SS/2018/080) and the HRB Centre for Primary Care Research (HRC/2014/01), and supported by the Royal College of Surgeons in Ireland Undergraduate Research Summer School.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study reuses publicly available data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Principal investigator statement: This study did not have a Principal Investigator, as it reports an analysis of publicly available administrative data.
Data Availability
The data that support the findings of this study are openly available in Zenodo at https://doi.org/10.5281/zenodo.3894539.